However, the control group (i.e., individuals with obesity not on these medications to treat type-2 diabetes or weight loss) reported these assessments for the current time point only
The STEER study investigated the risk of major adverse cardiovascular events (MACE) with Wegovy (semaglutide) 2.4 mg compared with tirzepatide treatment in people with overweight or obesity and established CVD without diabetes
Eleven days of food-intake measurement in a controlled rodent model cannot establish how appetite, eating behaviour or body weight would respond in humans
Consumers arent listening to endocrinologists
Genetics integration available: Add the Precision Peptide Genetic Test post-purchase ($99 one-time) for genetic insights across 14 health pathways
Sparkling water, infused water, unsweetened tea, protein shakes, balanced smoothies, and milk can all help you stay hydrated while adding variety to your day